Creatine and semaglutide: what the evidence actually says

What the prescribing evidence and clinical guidance tell us

The Wegovy Summary of Product Characteristics (the document regulators use to define how the medicine is used) lists no interaction with creatine. That is a meaningful starting point. Semaglutide acts on GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite. Creatine, by contrast, is taken up by skeletal muscle and converted to phosphocreatine, a short-burst energy store used during resistance exercise. The two substances do not share a metabolic pathway, and there is no published evidence of one affecting the absorption, clearance or effect of the other.

Clinical trial participants in the STEP programme (the semaglutide weight-management trials published in the New England Journal of Medicine) were eating a calorie-restricted diet and increasing physical activity alongside treatment. Both of those factors, combined with rapid weight loss, create conditions where muscle preservation becomes a real practical concern. Creatine has a robust evidence base for supporting lean mass during periods of energy deficit, making it a logical candidate for people in this position.

If you are weighing up your supplement choices during treatment, the dietary guidance that works well alongside Wegovy covers protein targets and food choices that matter just as much as any supplement decision.

The muscle-loss question: why this matters on semaglutide

Weight loss from any cause (including GLP-1 treatment) involves some reduction in lean tissue alongside fat. The proportion varies with diet quality, protein intake and activity level. Semaglutide's appetite-suppressing effect is substantial: in STEP 1, participants lost an average of around 15% of body weight over 68 weeks. That kind of reduction happens fast enough that muscle mass can fall if protein intake drops too low or resistance training is neglected.

Creatine works by increasing the availability of phosphocreatine in muscle, which supports strength output during short, intense effort. When combined with resistance exercise, it reliably helps people maintain or increase muscle mass during calorie restriction. This is why sports medicine clinicians and dietitians frequently discuss it in weight-management contexts, not as a weight-loss tool itself, but as a tool for keeping the weight you lose predominantly fat rather than muscle.

The appetite changes that come with semaglutide can make it harder to hit protein targets, so pairing a straightforward supplement with a structured approach to eating tends to produce better body-composition outcomes than either approach alone. Worth checking with your prescriber what daily protein intake looks like for your specific situation.

Hydration, kidney function and when to be cautious

Creatine supplementation increases water retention within muscle tissue, which raises total daily fluid requirements modestly. Under normal circumstances that is easy to manage. During semaglutide treatment, however, some people experience nausea, vomiting or diarrhoea, particularly when starting or after a dose increase. Those GI side effects can reduce fluid intake and increase fluid loss simultaneously. The combination is worth being aware of: if GI symptoms are significant, this is not the moment to add a supplement that increases your hydration demand without also increasing your fluid intake to match.

There is a separate consideration for anyone with reduced kidney function. Creatine is cleared renally, and though the evidence does not suggest creatine damages healthy kidneys, people with pre-existing chronic kidney disease should discuss supplementation with their prescriber or nephrologist before starting. The MHRA's Yellow Card scheme remains the route for reporting any unexpected reactions to medicines or supplements taken alongside them.

If you are considering a low-carbohydrate approach during treatment, the evidence on keto and semaglutide covers the dietary context in more detail, useful background if you are thinking about how creatine, carbohydrate availability and exercise performance interact on the same plan.

Starting semaglutide: the clinical assessment that comes first

It is worth saying plainly that semaglutide (Wegovy) is a prescription-only medicine. A prescriber reviews your medical history, current medicines and any supplements before treatment begins, and again before every repeat. That conversation is genuinely the right place to raise creatine, not because there is a known problem, but because your prescriber has the full picture. Some people also find it useful to read about which foods contain semaglutide, since understanding what the medicine is and is not found in can help frame those early conversations with your prescriber. If you are thinking about how to structure your approach before that first consultation, reading about what Wegovy treatment involves gives you a grounding in what to expect.

We understand that people researching supplements alongside weight-loss treatment are often already doing a lot of things right, tracking intake, thinking about body composition, not just the number on the scale. That kind of engagement with the process tends to produce better outcomes, and it is exactly what a clinician-led service is designed to support.

For people who have questions about cost before committing, the Wegovy pricing page sets out what private treatment involves in practice. When you are ready, you can start a free consultation and have your case reviewed the same day by a GPhC-registered prescriber.